Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer

Neoadjuvant FLOT regimen has shown promising results for the treatment of locally advanced gastric cancer, however SOX regimen remains the preferred chemotherapy in Eastern countries. Here the authors report that the two therapies result in similar outcomes, measured as clinical downstaging and path...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Birendra Kumar Sah, Benyan Zhang, Huan Zhang, Jian Li, Fei Yuan, Tao Ma, Min Shi, Wei Xu, Zhenglun Zhu, Wentao Liu, Chao Yan, Chen Li, Bingya Liu, Min Yan, Zhenggang Zhu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/69c89493ee9f46c0a12be336365c16b6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:69c89493ee9f46c0a12be336365c16b6
record_format dspace
spelling oai:doaj.org-article:69c89493ee9f46c0a12be336365c16b62021-12-02T17:31:23ZNeoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer10.1038/s41467-020-19965-62041-1723https://doaj.org/article/69c89493ee9f46c0a12be336365c16b62020-11-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-19965-6https://doaj.org/toc/2041-1723Neoadjuvant FLOT regimen has shown promising results for the treatment of locally advanced gastric cancer, however SOX regimen remains the preferred chemotherapy in Eastern countries. Here the authors report that the two therapies result in similar outcomes, measured as clinical downstaging and pathological response, in a phase II randomized clinical trial.Birendra Kumar SahBenyan ZhangHuan ZhangJian LiFei YuanTao MaMin ShiWei XuZhenglun ZhuWentao LiuChao YanChen LiBingya LiuMin YanZhenggang ZhuNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-8 (2020)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Birendra Kumar Sah
Benyan Zhang
Huan Zhang
Jian Li
Fei Yuan
Tao Ma
Min Shi
Wei Xu
Zhenglun Zhu
Wentao Liu
Chao Yan
Chen Li
Bingya Liu
Min Yan
Zhenggang Zhu
Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer
description Neoadjuvant FLOT regimen has shown promising results for the treatment of locally advanced gastric cancer, however SOX regimen remains the preferred chemotherapy in Eastern countries. Here the authors report that the two therapies result in similar outcomes, measured as clinical downstaging and pathological response, in a phase II randomized clinical trial.
format article
author Birendra Kumar Sah
Benyan Zhang
Huan Zhang
Jian Li
Fei Yuan
Tao Ma
Min Shi
Wei Xu
Zhenglun Zhu
Wentao Liu
Chao Yan
Chen Li
Bingya Liu
Min Yan
Zhenggang Zhu
author_facet Birendra Kumar Sah
Benyan Zhang
Huan Zhang
Jian Li
Fei Yuan
Tao Ma
Min Shi
Wei Xu
Zhenglun Zhu
Wentao Liu
Chao Yan
Chen Li
Bingya Liu
Min Yan
Zhenggang Zhu
author_sort Birendra Kumar Sah
title Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer
title_short Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer
title_full Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer
title_fullStr Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer
title_full_unstemmed Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer
title_sort neoadjuvant flot versus sox phase ii randomized clinical trial for patients with locally advanced gastric cancer
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/69c89493ee9f46c0a12be336365c16b6
work_keys_str_mv AT birendrakumarsah neoadjuvantflotversussoxphaseiirandomizedclinicaltrialforpatientswithlocallyadvancedgastriccancer
AT benyanzhang neoadjuvantflotversussoxphaseiirandomizedclinicaltrialforpatientswithlocallyadvancedgastriccancer
AT huanzhang neoadjuvantflotversussoxphaseiirandomizedclinicaltrialforpatientswithlocallyadvancedgastriccancer
AT jianli neoadjuvantflotversussoxphaseiirandomizedclinicaltrialforpatientswithlocallyadvancedgastriccancer
AT feiyuan neoadjuvantflotversussoxphaseiirandomizedclinicaltrialforpatientswithlocallyadvancedgastriccancer
AT taoma neoadjuvantflotversussoxphaseiirandomizedclinicaltrialforpatientswithlocallyadvancedgastriccancer
AT minshi neoadjuvantflotversussoxphaseiirandomizedclinicaltrialforpatientswithlocallyadvancedgastriccancer
AT weixu neoadjuvantflotversussoxphaseiirandomizedclinicaltrialforpatientswithlocallyadvancedgastriccancer
AT zhenglunzhu neoadjuvantflotversussoxphaseiirandomizedclinicaltrialforpatientswithlocallyadvancedgastriccancer
AT wentaoliu neoadjuvantflotversussoxphaseiirandomizedclinicaltrialforpatientswithlocallyadvancedgastriccancer
AT chaoyan neoadjuvantflotversussoxphaseiirandomizedclinicaltrialforpatientswithlocallyadvancedgastriccancer
AT chenli neoadjuvantflotversussoxphaseiirandomizedclinicaltrialforpatientswithlocallyadvancedgastriccancer
AT bingyaliu neoadjuvantflotversussoxphaseiirandomizedclinicaltrialforpatientswithlocallyadvancedgastriccancer
AT minyan neoadjuvantflotversussoxphaseiirandomizedclinicaltrialforpatientswithlocallyadvancedgastriccancer
AT zhenggangzhu neoadjuvantflotversussoxphaseiirandomizedclinicaltrialforpatientswithlocallyadvancedgastriccancer
_version_ 1718380617355231232